Application no. and date | 16757165.2 (espacenet) (Federated) (European Patent Register), 20160805 | Patent/reg. no. and date | DK/EP 3331915, 20210217 | Publication date | 20180613 | Priority no. and date | US 201562201461 P, 20150805 | EP pub. no. and date |
EP 3331915 20180613 | Effective date | | Applicant/owner | Amgen Research (Munich) GmbH, Staffelseestrasse 2
81477 München, DE | Applicant ref. no. | 1579097 | Inventor | FIEDLER, Walter, Husumerstrasse 8
20251 Hamburg, DE, WELLBROCK, Jasmin, Brucknerstrasse 31a
22083 Hamburg, DE, STAMM, Hauke, Hallerstrasse 1a
20146 Hamburg, DE, KLINGLER, Felix, Klecker Weg 14a
21244 Buchholz, DE | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 35/02 (2006.01) , C07K 16/28 (2006.01) , G01N 33/574 (2006.01) | Title | IMMUN-CHECKPOINT-INHIBITORER TIL ANVENDELSE TIL BEHANDLING AF BLODBÅRNE CANCERE | Int. application no. | EP2016068726 | Int. publication no. | WO2017021526 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|